Erratum: Clinical utility of patiromer, sodium zirconium cyclosilicate, and sodium polystyrene sulfonate for the treatment of hyperkalemia: an evidence-based review [Erratum].

Core Evidence Pub Date : 2019-02-27 eCollection Date: 2019-01-01 DOI:10.2147/CE.S205026

引用次数: 0

Abstract

[This corrects the article on p. 11 in vol. 12, PMID: 28356904.].

查看原文本刊更多论文

勘误:帕特罗默、环硅酸锆钠和聚苯乙烯磺酸钠治疗高钾血症的临床应用:一项基于证据的综述[勘误]。

[这更正了第12卷第11页的文章，PMID: 28356904]。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Core Evidence PHARMACOLOGY & PHARMACY-

自引率

0.00%

发文量

期刊介绍： Core Evidence evaluates the evidence underlying the potential place in therapy of drugs throughout their development lifecycle from preclinical to postlaunch. The focus of each review is to evaluate the case for a new drug or class in outcome terms in specific indications and patient groups The emerging evidence on new drugs is reviewed at key stages of development and evaluated against unmet needs